ATAI
Price
$2.73
Change
+$0.07 (+2.63%)
Updated
Jul 10 closing price
Capitalization
564.3M
38 days until earnings call
COUR
Price
$8.35
Change
-$0.48 (-5.44%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
2.21B
14 days until earnings call
Interact to see
Advertisement

ATAI vs COUR

Header iconATAI vs COUR Comparison
Open Charts ATAI vs COURBanner chart's image
ATAI Life Sciences
Price$2.73
Change+$0.07 (+2.63%)
Volume$3.93M
Capitalization564.3M
Coursera
Price$8.35
Change-$0.48 (-5.44%)
Volume$14.55K
Capitalization2.21B
ATAI vs COUR Comparison Chart in %
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. COUR commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a StrongBuy and COUR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (ATAI: $2.73 vs. COUR: $8.35)
Brand notoriety: ATAI and COUR are both not notable
ATAI represents the Biotechnology, while COUR is part of the Miscellaneous Commercial Services industry
Current volume relative to the 65-day Moving Average: ATAI: 97% vs. COUR: 163%
Market capitalization -- ATAI: $564.3M vs. COUR: $2.21B
ATAI [@Biotechnology] is valued at $564.3M. COUR’s [@Miscellaneous Commercial Services] market capitalization is $2.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The market cap for tickers in the [@Miscellaneous Commercial Services] industry ranges from $80.94B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B. The average market capitalization across the [@Miscellaneous Commercial Services] industry is $5.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileCOUR’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • COUR’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATAI and COUR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while COUR’s TA Score has 3 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 4 bearish.
  • COUR’s TA Score: 3 bullish, 8 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than COUR.

Price Growth

ATAI (@Biotechnology) experienced а -1.44% price change this week, while COUR (@Miscellaneous Commercial Services) price change was -2.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

The average weekly price growth across all stocks in the @Miscellaneous Commercial Services industry was +2.56%. For the same industry, the average monthly price growth was +4.45%, and the average quarterly price growth was +14.81%.

Reported Earning Dates

ATAI is expected to report earnings on Nov 18, 2025.

COUR is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Miscellaneous Commercial Services (+2.56% weekly)

The sector produces general business services, and are not classified elsewhere. For example, FleetCor Technologies provides fuel cards and workforce payment products and services; Copart, Inc. provides online vehicle auction and remarketing services across various nations; Equifax Inc. collects and aggregates credit information on consumers and businesses worldwide, along with selling credit monitoring and fraud-prevention services. Many of the companies in this category have multi-billion market capitalizations.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COUR($2.21B) has a higher market cap than ATAI($564M). ATAI YTD gains are higher at: 105.263 vs. COUR (3.882). COUR has higher annual earnings (EBITDA): -129.13M vs. ATAI (-145.09M). COUR has more cash in the bank: 722M vs. ATAI (98.2M). COUR has less debt than ATAI: COUR (6.6M) vs ATAI (26.7M). COUR has higher revenues than ATAI: COUR (636M) vs ATAI (1.86M).
ATAICOURATAI / COUR
Capitalization564M2.21B26%
EBITDA-145.09M-129.13M112%
Gain YTD105.2633.8822,711%
P/E RatioN/AN/A-
Revenue1.86M636M0%
Total Cash98.2M722M14%
Total Debt26.7M6.6M405%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
15
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAICOUR
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 9 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIEZX15.60N/A
N/A
MM S&P 500® Index R5
AMCGX10.30N/A
N/A
Alger Mid Cap Growth B
FBSRX36.89N/A
N/A
Franklin Mutual U.S. Mid Cap Value R
LNGZX42.57N/A
N/A
Columbia Greater China Inst
AKRIX73.81N/A
N/A
Akre Focus Instl

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+2.63%
MNMD - ATAI
53%
Loosely correlated
+4.92%
RXRX - ATAI
47%
Loosely correlated
+2.24%
CYBN - ATAI
45%
Loosely correlated
+1.06%
COUR - ATAI
45%
Loosely correlated
-5.44%
VCYT - ATAI
45%
Loosely correlated
+3.54%
More

COUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, COUR has been loosely correlated with UDMY. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if COUR jumps, then UDMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COUR
1D Price
Change %
COUR100%
+2.56%
UDMY - COUR
48%
Loosely correlated
+1.60%
DNB - COUR
48%
Loosely correlated
N/A
ARLO - COUR
46%
Loosely correlated
-0.90%
ATAI - COUR
45%
Loosely correlated
+1.14%
EVLV - COUR
33%
Loosely correlated
+0.85%
More